Clinical Trial Update: Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a study evaluating a triplet of utomilumab, cetuximab, and irinotecan in patients with metastatic colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
• Utomilumab (utomilumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 1 | Status: COMPLETED